ARCHIVE

• Sales of Kyowa Hakko's Allelock Expected to Rise 35% in 2nd Half
  January 3, 2005

• Schering-Plough to Use New Formulation, New Evidence to Boost Sales of Claritin
  January 3, 2005

• Eisai Recieves A Positive Opinion for Zonegran Approval from EMEA
  January 3, 2005

• BUSINESS NEWS IN BRIEF
  January 3, 2005

• DIAGNOSTIC NEWS IN BRIEF
  January 3, 2005

• Reform Council, Korosho Finally Agree on "Mixed Medical Care"
  January 3, 2005

• EDITOR'S NOTE
  January 3, 2005

• 11 Ingredients/24 Products Including Add. Formulation Products
  January 3, 2005

• Special interview
  January 3, 2005

• REGULATORY NEWS IN BRIEF
  January 3, 2005

• New year's Messages
  January 3, 2005

• Chuikyo's Role Should Be Restricted to Price Setting: Council
  January 3, 2005

• PhRMA to Actively Discuss Healthcare Reform
  January 3, 2005

• NHI Listing of Epzicom, Lexiva Recommended
  January 3, 2005

• Sanofi-Synthelabo, Aventis Pharma to Consolidate Their Businesses in January 2005
  December 27, 2004

• Kaken to Make Trafermin Blockbuster by Add. Indication, Formulation
  December 27, 2004

• Taisho Starts PI Trials for Antidepressant TS-041
  December 27, 2004

• Non-wholesale Business to Account for 50% of Ordinary Profits in 2010: Suzuken
  December 27, 2004

• LTT to Start PIIa Trial on PC-SOD in Japan
  December 27, 2004

• Wholesalers' Distribution Cost Ratio Higher for Pharmacies: FJPWA Survey
  December 27, 2004

ページ

• « 先頭
• ‹ Prev
• …
• 489
• 490
• 491
• 492
• 493
• 494
• 495
• 496
• 497
• …
• Next ›
• 最終 »